Nisha Rathode (Editor)

Mark Pepys

Updated on
Share on FacebookTweet on TwitterShare on LinkedInShare on Reddit
Covid-19
Nationality  British
Role  Professor

Name  Mark Pepys
Notable awards  FRS (1993)
Fields  Amyloidosis
Mark Pepys wwwuclacuknewsnewsarticles1010profmarkpepy
Institutions  University College London
Alma mater  UCL Medical School (MBBS) University of Cambridge (BA, PhD)
Thesis  Role of complement in induction of the allergic response (1973)

Education  University of Cambridge

What is Amyloidosis? Diagnosis, treatment concepts, and future - Dr. Mark Pepys


Sir Mark Brian Pepys FRS was until 2011 Professor of Medicine at University College London and Head of Medicine at the Hampstead Campus and the Royal Free Hospital.

Contents

Education

Pepys finished his early education at the University of Cambridge, and then qualified as a medical doctor at University College London Medical School. He then returned to Cambridge where he was awarded a PhD in Immunology in 1973.

Awards and honours

Pepys won the GlaxoSmithKline Prize in 2007 "for his excellent work as a clinical scientist who has identified specific proteins as new therapeutic targets and developed novel drugs with potential use in amyloidosis, Alzheimer's disease and cardiovascular disease". In 1993, Pepys was elected a Fellow of the Royal Society (FRS). His nomination reads:

In 1999 he became director of the University College London Centre for Amyloidosis and Acute Phase Proteins.

Mark Pepys has recently won the 2008 Ernst Chain Prize for his work on amyloid diseases, established by Imperial College London in recognition of leaders in their fields.

Pepys was knighted in the 2012 New Year Honours for services to biomedicine.

References

Mark Pepys Wikipedia


Topics
 
B
i
Link
H2
L